Skip to main content
OpenTrials

Clinical trial condition

Asthma

Explore clinical trials studying Asthma. Study availability and eligibility vary by location and protocol.

3,549 public trials 274 recruiting studies
Refine in advanced search Browse all conditions

Asthma trial results

Completed

Evaluation of Tiotropium 2.5 and 5 µg Once Daily Delivered Via the Respimat Inhaler Compared to Placebo in Patient With Moderate to Severe Persistent Asthma

NCT01340209

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • 205.464.81020 Boehringer Ingelheim Investigational Site Asahikawa, Hokkaido, Japan
  • 205.464.81031 Boehringer Ingelheim Investigational Site Atsugi, Kanagawa, Japan
  • 205.464.81029 Boehringer Ingelheim Investigational Site Chigasaki, Kanagawa, Japan
  • 205.464.81011 Boehringer Ingelheim Investigational Site Chino, Nagano, Japan
View all 55 locations
View Trial Details
Completed

Efficacy and Safety of 4 Weeks of Treatment With Inhaled BI 1744 CL in Patients With Asthma

NCT00467740

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • 1222.6.064 Arthur F. Gelb Medical Corporation, Lakewood Lakewood, California, United States
  • 1222.6.062 Boehringer Ingelheim Investigational Site Los Angeles, California, United States
  • 1222.6.066 Allergy & Asthma Medical Group and Rsrch Ctr, APC San Diego, California, United States
  • 1222.6.069 Allergy Associates Medical Group San Diego, California, United States
View all 37 locations
View Trial Details
Completed

A Study of the Safety and Efficacy of 4 Doses of BI 1744 CL Delivered Via the Respimat in Patients With Asthma.

NCT01013753

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • 1222.27.43002 Boehringer Ingelheim Investigational Site Linz, Austria
  • 1222.27.43004 Boehringer Ingelheim Investigational Site Schlüsslberg, Austria
  • 1222.27.43001 Boehringer Ingelheim Investigational Site Thalheim bei Wels, Austria
  • 1222.27.43003 Boehringer Ingelheim Investigational Site Vienna, Austria
View all 27 locations
View Trial Details
Completed

Efficacy and Safety of 4 Weeks Treatment With Inhaled BI 1744 CL in Patients With COPD.

NCT00452400

Conditions
Asthma, Bronchial Diseases, Chronic Disease, +11 more
Locations
  • 1222.5.03 Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States
  • 1222.5.07 Boehringer Ingelheim Investigational Site Lakewood, California, United States
  • 1222.5.14 Boehringer Ingelheim Investigational Site Denver, Colorado, United States
  • 1222.5.13 Boehringer Ingelheim Investigational Site Wheat Ridge, Colorado, United States
View all 42 locations
View Trial Details
Completed

AZISAST Study: AZIthromycin in Severe ASThma Study

NCT00760838

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Onze Lieve Vrouw Ziekenhuis Aalst Aalst, Belgium
  • ZNA Middelheim Antwerp, Belgium
  • AZ Sint-Jan Brugge Bruges, Belgium
  • Ghent University Hospital Ghent, Belgium
View Trial Details

Related conditions